132 related articles for article (PubMed ID: 18540247)
1. A study of anthropomorphic and biochemical characteristics in girls with central precocious puberty and thelarche variant.
Su PH; Wang SL; Chen JY; Chen SJ; Ke JC
J Pediatr Endocrinol Metab; 2008 Mar; 21(3):213-20. PubMed ID: 18540247
[TBL] [Abstract][Full Text] [Related]
2. Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 in girls with premature thelarche.
Sales DS; Moreira AC; Camacho-Hübner C; Ricco RG; Daneluzzi JC; Campos AD; Martinelli CE
J Pediatr Endocrinol Metab; 2003; 16(6):827-33. PubMed ID: 12948294
[TBL] [Abstract][Full Text] [Related]
3. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
Juul A; Scheike T; Nielsen CT; Krabbe S; Müller J; Skakkebaek NE
J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
[TBL] [Abstract][Full Text] [Related]
4. Irreversible increase of serum IGF-1 and IGFBP-3 levels in GnRH-dependent precocious puberty of different etiologies: implications for the onset of puberty.
Belgorosky A; Rivarola MA
Horm Res; 1998; 49(5):226-32. PubMed ID: 9568807
[TBL] [Abstract][Full Text] [Related]
5. Basal luteinizing hormone/follicle stimulating hormone ratio in diagnosis of central precocious puberty.
Supornsilchai V; Hiranrat P; Wacharasindhu S; Srivuthana S; Aroonparkmongkol S
J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S145-51. PubMed ID: 12929982
[TBL] [Abstract][Full Text] [Related]
6. Premature thelarche and central precocious puberty: the relationship between clinical presentation and the gonadotropin response to luteinizing hormone-releasing hormone.
Pescovitz OH; Hench KD; Barnes KM; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1988 Sep; 67(3):474-9. PubMed ID: 3137242
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound assessment of breast development: distinction between premature thelarche and precocious puberty.
Youn I; Park SH; Lim IS; Kim SJ
AJR Am J Roentgenol; 2015 Mar; 204(3):620-4. PubMed ID: 25714294
[TBL] [Abstract][Full Text] [Related]
8. Serum insulin-like growth factor-I (IGF-I) and IGF binding protein-3 levels in children with precocious puberty treated with gonadotropin-releasing hormone analog without or in combination with cyproterone acetate.
Verrotti A; Ferrari M; Sabatino G; Morgese G; Chiarelli F
Gynecol Endocrinol; 1997 Aug; 11(4):243-50. PubMed ID: 9272420
[TBL] [Abstract][Full Text] [Related]
9. Central precocious puberty: clinical and laboratory features.
Chemaitilly W; Trivin C; Adan L; Gall V; Sainte-Rose C; Brauner R
Clin Endocrinol (Oxf); 2001 Mar; 54(3):289-94. PubMed ID: 11298079
[TBL] [Abstract][Full Text] [Related]
10. The response to gonadotropin releasing hormone (GnRH) stimulation test does not predict the progression to true precocious puberty in girls with onset of premature thelarche in the first three years of life.
Bizzarri C; Spadoni GL; Bottaro G; Montanari G; Giannone G; Cappa M; Cianfarani S
J Clin Endocrinol Metab; 2014 Feb; 99(2):433-9. PubMed ID: 24297793
[TBL] [Abstract][Full Text] [Related]
11. [The differentiation between premature thelarche and pubertas praecox on the basis of clinical, hormonal and radiological findings].
Pohlenz J; Habermehl P; Wemme H; Grimm W; Schönberger W
Dtsch Med Wochenschr; 1994 Sep; 119(39):1301-6. PubMed ID: 7924927
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-I and IGF binding protein-3 remain high after GnRH analogue therapy in girls with central precocious puberty.
Kanety H; Karasik A; Pariente C; Kauschansky A
Clin Endocrinol (Oxf); 1996 Jul; 45(1):7-12. PubMed ID: 8796132
[TBL] [Abstract][Full Text] [Related]
13. Use of combined Gn-RH agonist and hGH therapy for better attining the goals in precocious puberty treatment.
Tatò L; Saggese G; Cavallo L; Antoniazzi F; Corrias A; Pasquino AM; Cisternino M
Horm Res; 1995; 44 Suppl 3():49-54. PubMed ID: 8719441
[TBL] [Abstract][Full Text] [Related]
14. [The significance and characteristics of the LHRH test in diagnosing precocious puberty development in girls: the stimulated LH/FSH quotient differentiates between central precocious puberty and premature thelarche].
Partsch CJ; Hümmelink R; Lorenzen F; Sippell WG
Monatsschr Kinderheilkd; 1989 May; 137(5):284-8. PubMed ID: 2525665
[TBL] [Abstract][Full Text] [Related]
15. Evidence for increased ovarian follicular activity in girls with premature thelarche.
Crofton PM; Evans NE; Wardhaugh B; Groome NP; Kelnar CJ
Clin Endocrinol (Oxf); 2005 Feb; 62(2):205-9. PubMed ID: 15670197
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic central precocious puberty in girls: presentation factors.
Prété G; Couto-Silva AC; Trivin C; Brauner R
BMC Pediatr; 2008 Jul; 8():27. PubMed ID: 18601733
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous serum gonadotropin concentrations in the evaluation of precocious puberty.
Neely EK; Wilson DM; Lee PA; Stene M; Hintz RL
J Pediatr; 1995 Jul; 127(1):47-52. PubMed ID: 7608810
[TBL] [Abstract][Full Text] [Related]
18. Serum bioactive follicle-stimulating hormone levels in girls with precocious sexual development.
Wang C; Zhong CQ; Leung A; Low LC
J Clin Endocrinol Metab; 1990 Mar; 70(3):615-9. PubMed ID: 2106526
[TBL] [Abstract][Full Text] [Related]
19. Serum leptin levels in patients with progressive central precocious puberty.
Heger S; Partsch CJ; Peter M; Blum WF; Kiess W; Sippell WG
Pediatr Res; 1999 Jul; 46(1):71-5. PubMed ID: 10400137
[TBL] [Abstract][Full Text] [Related]
20. [Value of basal serum gonadotropin levels in the diagnosis of precocious puberty in girls].
Liang JT
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Dec; 14(12):942-5. PubMed ID: 23234783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
